Image Ben Hargreaves Oncology The future is now: AI and more effective cancer screening Ben Hargreaves examines how AI cancer diagnosis is currently being implemented, and how it could evolve in the years ahead, including the potential for the exploration of digital biomarkers R&D Was the response to monkeypox a success? The viral disease that infected a number of people across various countries caused significant alarm for its potential to spread rapidly. Market Access What happened to all the antibiotics? Across the world, there are reports of shortages of common antibiotics. R&D Can genetic data be a magic bullet for drug R&D? Drug development has long been an issue for the pharma industry, due to the expense and the high failure rate of potential treatments. Load more results
Oncology The future is now: AI and more effective cancer screening Ben Hargreaves examines how AI cancer diagnosis is currently being implemented, and how it could evolve in the years ahead, including the potential for the exploration of digital biomarkers
R&D Was the response to monkeypox a success? The viral disease that infected a number of people across various countries caused significant alarm for its potential to spread rapidly.
Market Access What happened to all the antibiotics? Across the world, there are reports of shortages of common antibiotics.
R&D Can genetic data be a magic bullet for drug R&D? Drug development has long been an issue for the pharma industry, due to the expense and the high failure rate of potential treatments.
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
